Benlysta Shows Promise for Lupus
People with lupus given the first in a new class of experimental drugs that targets the disease process did better than those given standard treatment, according to one-year results of a large clinical trial.
Click here to read the full story.
The content has been reported and it will be reviewed by a moderator.
